Peter Attia· MD
So the study that's been completed is just AKG time release, so none of the vitamins. Uh, and it's placeboc controlled and as many parameters as we can measure. So hopefully it'll show something.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So the study that's been completed is just AKG time release, so none of the vitamins. Uh, and it's placeboc controlled and as many parameters as we can measure. So hopefully it'll show something.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The first study we did was with a timereleas version of AKG that with the PDL healthate. Yeah. Um Okay. I'd like to hear more about that. That's finished. And uh we're just analyzing data. So I can't tell you much data, but it we finished the trial. We did six-month intervention and three-month follow-up.
In that case, we're just testing the time release AKG. We didn't include the vitamins because we're trying to get some mechanistic information. We don't want confounders in there.
Um, and that's why we wanted to do a controlled placebo double-blinded clinical trial at the university. In that case, we're just testing the time release AKG. We didn't include the vitamins because we're trying to get some mechanistic information.